Operating Lease, Right-of-Use Asset of BridgeBio Pharma, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BridgeBio Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • BridgeBio Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $6,553,000, a 1.8% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BridgeBio Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,553,000 +$114,000 +1.8% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $6,186,000 -$1,081,000 -15% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $7,166,000 -$886,000 -11% 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q4 2024 $5,767,000 -$2,260,000 -28% 31 Dec 2024 10-Q 29 Oct 2025 2025 Q3
Q3 2024 $6,439,000 -$2,893,000 -31% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $7,267,000 -$2,547,000 -26% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $8,052,000 -$2,480,000 -24% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $8,027,000 -$2,651,000 -25% 31 Dec 2023 10-K 20 Feb 2025 2024 FY
Q3 2023 $9,332,000 -$2,406,000 -20% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $9,814,000 -$3,036,000 -24% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $10,532,000 -$3,404,000 -24% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $10,678,000 -$5,229,000 -33% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $11,738,000 -$5,370,000 -31% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $12,850,000 -$3,114,000 -20% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $13,936,000 +$939,000 +7.2% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $15,907,000 -$601,000 -3.6% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $17,108,000 +$7,464,000 +77% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $15,964,000 +$5,499,000 +53% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $12,997,000 +$4,142,000 +47% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $16,508,000 +$6,508,000 +65% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $9,644,000 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $10,465,000 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $8,855,000 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $10,000,000 31 Dec 2019 10-K 03 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.